BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 703354)

  • 1. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
    Obalek S; Haftek M; Sliński W
    Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactivity in primary carcinoma of the lung and its relation to prognosis.
    Wanebo HJ; Rao B; Miyazawa N; Martini N; Middleman MP; Oettgen HF; Beattie EJ
    J Thorac Cardiovasc Surg; 1976 Sep; 72(3):339-50. PubMed ID: 183063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)].
    Bürkle PA; Tönnesmann E; Ahnefeld S; Nobbe F; Federlin K
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):153-65. PubMed ID: 134535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dinitrochlorobenzene contact sensitization in pulmonary tuberculosis.
    Malaviya AN; Sehgal KL; Kumar R; Dingley HB
    Clin Exp Immunol; 1975 Dec; 22(3):399-403. PubMed ID: 1225485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of skin reactivity in patients with bronchogenic carcinoma grouped according to the TNM classification.
    Plesnicar S; Rudolf Z; Lavrencic D
    Neoplasma; 1977; 24(6):633-40. PubMed ID: 593468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactions to dinitrochlorobenzene in patients with neuroblastoma and survival.
    Helson L
    J Natl Cancer Inst; 1976 Sep; 57(3):723-4. PubMed ID: 978776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Various indices of cellular immunity in cancer and chronic diseases of the stomach].
    Riatsep VI; Saliev VP; Mianniko MKh
    Vopr Onkol; 1979; 25(12):22-6. PubMed ID: 516578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
    Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
    J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
    Lipenský R; Urban K
    Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
    [No Abstract]   [Full Text] [Related]  

  • 13. A technique for intensifying BCG sensitivity.
    Parmett SR; Klein E
    J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin tests of delayed hypersensitivity (tuberculin, DNCB) in the immunologic study of patients with primary cancer of the lung].
    Bariffi F; Illiano A; Tranfa CM; Del Prato B
    Arch Monaldi; 1978; 33(4):239-50. PubMed ID: 756707
    [No Abstract]   [Full Text] [Related]  

  • 15. A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer.
    Cunningham TJ; Daut D; Wolfgang PE; Mellyn M; Maciolek S; Sponzo RW; Horton J
    Cancer; 1976 Apr; 37(4):1696-1700. PubMed ID: 1260685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hapten-specific lymphocyte transformation in humans sensitized with NDMA or DNCB.
    SoebergB ; Andersen V
    Clin Exp Immunol; 1976 Sep; 25(3):490-2. PubMed ID: 963911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum.
    Rao B; Wanebo HJ; Pinsky C; Stearns M; Oettgen HF
    Surg Gynecol Obstet; 1977 May; 144(5):677-81. PubMed ID: 850850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Delayed hypersensitivity tests: PPD, DNCB and distreptase in patients with primary lung cancer].
    Słowik-Gabryelska A; Krzyśko R; Menzel-Czapiewska A; Lukaszewicz M; Gizycka D
    Pol Tyg Lek; 1978 Aug; 33(33):1299-302. PubMed ID: 704429
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between phytohemagglutinin skin test and delayed cutaneous hypersensitivity to dinitrochlorobenzene in cancer patients.
    Sone S; Yata K; Tsubura E
    Gan; 1976 Aug; 67(4):621-2. PubMed ID: 1024855
    [No Abstract]   [Full Text] [Related]  

  • 20. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.